What Monistat does

Monistat is an over-the-counter (OTC) women's health brand focused on self-treatment of vulvovaginal candidiasis (yeast infections) and adjacent feminine care needs. The brand is owned by Prestige Consumer Healthcare Inc. and operates through the legal entity Insight Pharmaceuticals LLC, domiciled in Tarrytown, New York. The core product portfolio consists of miconazole nitrate-based antifungal treatments offered in 1-day, 3-day, and 7-day regimens, supplemented by a tioconazole 1-day option, combination care SKUs (antifungal plus anti-itch cream and cooling wipes), and a separate MONISTAT Maintain line built around a borate- and boric-acid-based complex for ongoing vaginal health maintenance. A combined UTI test and pain relief kit extends the portfolio into adjacent urinary-health self-care.

The business model is a classic OTC consumer health franchise: branded SKUs are distributed through major U.S. mass and drug retail channels (CVS, Walgreens, Walmart, Target, Amazon) and additionally in Canada and Australia, with revenue generated through unit sales at retail price points typically in the $15-$25 range for treatment courses. Go-to-market is anchored to a healthcare professional (HCP) recommendation channel, evidenced by a dedicated HCP portal, patient education materials, and the brand's #1 Gynecologist Recommended positioning in the U.S. OTC antifungal category. Patient outcomes (rapid symptomatic relief) and HCP endorsement drive repeat purchase, while formulation breadth across dosing durations and the adjacent Maintain and UTI categories aim to capture a larger share of each episode of care.

The category itself is mature and clinically well-defined: roughly three out of four women experience at least one lifetime episode of vulvovaginal candidiasis, and CDC guidance enumerates the topical azole regimens that Monistat's product line covers. The brand's competitive position rests on multi-format coverage, deep retail distribution, and clinician-preferred status, which together suppress private-label encroachment relative to less-endorsed OTC brands. Operating surface is lean at the brand level (1-10 employees), consistent with a brand-team structure inside a larger consumer healthcare parent.

Name

Monistat

Legal name

Insight Pharmaceuticals LLC

Website

https://monistat.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Monistat is a U.S.-led OTC women's health brand sold in the U.S., Canada, and Australia, offering miconazole and tioconazole-based antifungal treatments, boric acid maintenance products, and UTI self-care kits through mass, drug, and e-commerce retail channels, anchored by HCP recommendation.

Ownership category

akta.pro rank

Product category

Consumer Healthcare / OTC Pharmaceutical

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC)

Keywords

• Yeast infection treatment
• Feminine care products
• OTC antifungal medications
• Vaginal health products
• Boric acid suppositories

Headquarters

HQ city

Lynchburg

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Marketing or Sales, Supply Chain, Operations, Personnel, Technology or R&D

Revenue model

1. OTC Yeast Infection Treatment Products: Monistat generates revenue through the sale of over-the-counter yeast infection treatment products including MONISTAT 1, 3, and 7-day treatments. Revenue comes from consumer purchases at retail stores and pharmacies without requiring a prescription.
2. Feminine Care / Maintain Products: Revenue from the Monistat Maintain line including boric acid suppositories, feminine cleansers, cleansing wipes, and combination kits for ongoing vaginal health maintenance and odor control.
3. Symptom Relief Products: Sale of symptom relief products including Chafing Relief Powder Gel, Instant Itch Relief Spray, and Instant Itch Relief Cream for feminine care needs beyond yeast infection treatment.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Monistat is an over-the-counter (OTC) consumer healthcare brand that manufactures and sells yeast infection treatments containing miconazole nitrate in 1-day, 3-day, and 7-day dosage forms, along with a feminine care line for symptom relief (chafing, itching) and a Maintain line featuring boric acid-based products for vaginal pH balance and odor control. The brand sells directly to consumers without requiring a prescription through major retail pharmacies, drugstores, and its own e-commerce platform.

Product overview

Monistat is a consumer healthcare company offering over-the-counter (OTC) yeast infection treatments and vaginal health products. The product portfolio consists of three core yeast infection treatment lines (MONISTAT® 1, 3, and 7) differentiated by treatment duration and dosage strength, all containing the antifungal active ingredient miconazole nitrate. The MONISTAT® Care™ sub-brand extends beyond cure to provide feminine care symptom relief products including chafing relief and instant itch relief. The newer MONISTAT® Maintain line offers vaginal odor control and pH balance products featuring boric acid formulations including feminine cleansers, wipes, and suppositories, plus a UTI test and pain relief kit. Together, these products address the full lifecycle from acute yeast infection treatment to ongoing feminine wellness maintenance.

Differentiator

Problem solved

Functional benefit

Brands

• MONISTAT Care: Line of feminine care products including Chafing Relief Powder Gel, Instant Itch Relief Spray, and Instant Itch Relief Cream.
• MONISTAT Maintain

Products and services

• MONISTAT 1-Day Treatment Combination Pack Maximum-strength 1-day yeast infection treatment containing 1200 mg miconazole nitrate in one Ovule dose, designed for consumers seeking the shortest treatment course.
• MONISTAT 1 Prefilled Ointment 6.5% tioconazole ointment in one dose with 1 ready-to-use prefilled applicator, formulated for patients sensitive to high concentrations of miconazole or cream ingredients.
• MONISTAT 3-Day Treatment Combination Pack (with Ovule) 3-day treatment with 3 Ovule inserts containing 200 mg miconazole nitrate each, for consumers wanting a less-concentrated treatment option.
• MONISTAT 3-Day Treatment Combination Pack (with suppositories) 3-day treatment with 3 vaginal suppositories for yeast infection cure.
• MONISTAT 3-Day Treatment Combination Pack (with prefilled cream) 3-day treatment with 3 prefilled cream applicators plus external itch cream for comprehensive symptom relief.
• MONISTAT 7-Day Treatment Combination Pack 7-dose low-dose treatment with 100 mg miconazole nitrate per dose, includes 7 prefilled cream applicators and external itch relief cream. Recommended by CDC guidelines for pregnant women and diabetic patients.
• Chafing Relief Powder Gel Daily protection and relief from painful chafing and irritation. Contains dimethicone for a moisture-control barrier that fights friction in delicate areas; fragrance-free, non-messy, non-staining.
• Instant Itch Relief Spray Maximum-strength OTC spray with 20% benzocaine for continuous, touch-free application delivering lasting intense itch relief; paraben-free.
• Instant Itch Relief Cream 1% hydrocortisone cream for long-lasting intense itch relief; fragrance-free and hypoallergenic.
• Feminine Cleanser with Boric Acid Fragrance-free gentle wash that cleanses away feminine odor and discharge without irritating sensitive skin; contains a pH-balanced boric acid complex, gynecologist tested, safe for everyday use (10oz and 16oz sizes).
• Feminine Cleansing Wipes with Boric Acid Fragrance-free plant-based wipes that remove odor and discharge using a pH-balanced complex matching healthy external intimate area pH. Not intended to treat vaginal yeast infection.
• Boric Acid Vaginal Suppositories Easy-to-insert unscented suppositories containing boric acid for vaginal odor control and pH balance; free of synthetic dyes, perfumes, and preservatives. Not intended to treat vaginal yeast infection.
• Boric Acid Suppository & Wipes Kit 2-in-1 convenience kit containing 10 boric acid vaginal suppositories (600mg each) plus 10 individually wrapped vaginal wipes; gynecologist tested.
• Maintain UTI Test & Pain Relief Kit 2-in-1 kit with 2 urinary tract infection test strips plus 12 maximum strength pain relief tablets for temporary relief from urinary pain, burning, and urgency.

Quantifiable outcome

• Relieves symptoms 4x faster than prescription fluconazole - often within 4 hours vs 16-24 hours for fluconazole
• +4 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Diflucan (fluconazole): Pfizer/Viatris's oral prescription fluconazole is the primary pharmaceutical alternative to Monistat; OTC self-selection away from Diflucan is the core defensibility driver cited in Monistat's clinical messaging and differentiation.
• Canesten: Bayer's global OTC antifungal brand (clotrimazole), Canesten is the international category leader in self-diagnosis OTC yeast infection treatment, demonstrating the global brand model Monistat could replicate beyond its current NA/AU footprint.

Direct peers

• RepHresh: A Church & Dwight brand, RepHresh sells pH-balancing gels, cleansers, and Pro-B probiotics — directly comparable to Monistat Maintain's boric acid pH-balanced cleansers and suppositories in the feminine microbiome category.
• Vagisil: Owned by Combe Incorporated, Vagisil is the leading OTC brand for feminine itch and chafing relief, directly competing with Monistat Care (Chafing Relief Powder Gel, Instant Itch Relief Spray/Cream) for the same shelf placement and consumer OTC occasion.
• Summer's Eve: Also a brand under Prestige Consumer Healthcare, Summer's Eve is the dominant feminine wash and wipe brand and competes head-to-head with Monistat Maintain for shelf space and recurring feminine care wallet share.
• AZO: A brand of i-Health, Inc. (Chr. Hansen/Amarelli-owned), AZO markets OTC yeast infection treatments and UTI test strips and pain relief, directly overlapping Monistat's core antifungal franchise and Maintain UTI test & pain relief kit.

Others

• Combe Incorporated: The parent company of Vagisil, Combe is a private peer conglomerate mirroring Prestige Consumer Healthcare's role as Monistat's parent, providing a useful comparable for portfolio-level brand investment and OTC channel economics.

Emerging players

• Love Wellness: A fast-growing DTC women's wellness brand with a boric acid suppository product and broader feminine care range, sharing Monistat Maintain's positioning and competing for the same millennial/Gen Z convenience-channel consumer.
• The Honey Pot Company: Plant-based feminine care brand with washes, wipes, and suppositories sold through Target, Walmart, and DTC, partially overlapping Monistat Maintain's herbal/gentle positioning and increasingly competing for the same mainstream grocery shelf.
• pH-D Feminine Health: An emerging D2C brand built around boric acid vaginal suppositories, directly competing with Monistat Maintain suppositories via a strong DTC and influencer funnel and threatening the brand's first-mover position in branded boric acid.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/61556757329208

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Monistat